Veru

Price & Volume

Track all markets on TradingView

Stats

See more
Open
$0.63
Previous Close
$0.62
Day Range
$0.59-$0.63
52W Range
$0.36-$1.92
Market Cap
$90M
Shares Short
12M

Financials

See more
Revenue (12 Mos)
$14M
Revenue Growth (YoY)
18.3%
Gross Profit (12 Mos)
$30.5M
Diluted EPS
-$0.30

News

See more

Yahoo Finance • 11 months ago

Veru Announces Proposed Public Offering of Common Stock

Yahoo Finance • last year

Veru Reports Muscle Data from 5 Clinical Studies of Enobosarm that Support the Advancement of Enobosarm in Combination with Weight-Loss GLP-1 Drugs, Ozempic®, Wegovy®, or Mounjaro®, to Optimize Weight Loss by Preventing Muscle Wasting and Further Increasing Fat Loss in a Phase 2b Obesity Clinical Study

Yahoo Finance • last year

Veru Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral Acute Respiratory Distress Syndrome (ARDS)

Yahoo Finance • last year

Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023

About

CEO
Dr. Mitchell S. Steiner F.A.C.S., M.D.
Address
2916 North Miami Avenue, Miami, FL, United States, 33127
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
189